Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Drug-Receptor Interaction: Antagonist01:28

Drug-Receptor Interaction: Antagonist

4.8K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
4.8K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.9K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.9K
Drug-Receptor Interactions01:29

Drug-Receptor Interactions

7.3K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.3K
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

345
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

scDeepAPA: a deep learning framework for single-cell alternative polyadenylation identification.

Briefings in bioinformatics·2026
Same author

Beyond the canonical: The role of post-transcriptional regulation in drug-target interaction prediction.

PLoS computational biology·2026
Same author

Correction of rotational position error in Fourier space for ptychography.

Optics express·2026
Same author

Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

Cancer research·2026
Same author

High Desalination Performance of Polyamide Composite Reverse Osmosis Membranes Based on Integrated Diamine Monomers.

Membranes·2026
Same author

Green leaching strategies for recovering critical metals from spent lithium-ion batteries using fruit peels and coffee waste.

Waste management (New York, N.Y.)·2026

Related Experiment Video

Updated: Jan 13, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

DCGAT-DTI: dynamic cross-graph attention network for drug-target interaction prediction.

Abrar Rahman Abir1, Muhtasim Noor Alif2, Wencai Zhang3

  • 1Department of Computer Science and Engineering, Bangladesh University of Engineering and Technology, Dhaka 1000, Bangladesh.

Bioinformatics Advances
|January 9, 2026
PubMed
Summary

DCGAT-DTI enhances drug discovery by predicting drug-target interactions using a novel deep learning framework. This method effectively models interdependencies between drugs and proteins, outperforming existing approaches in various scenarios.

More Related Videos

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.7K
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

4.5K

Area of Science:

  • Bioinformatics
  • Computational Chemistry
  • Drug Discovery

Background:

  • Drug-target interaction (DTI) prediction is crucial for accelerating drug discovery.
  • Current methods often analyze drug-drug and protein-protein similarities independently, failing to capture cross-modal dependencies.
  • This limitation hinders the comprehensive modeling of interactions between chemical compounds and proteins.

Purpose of the Study:

  • To propose DCGAT-DTI, a deep learning framework designed to improve DTI prediction.
  • To dynamically model intra- and cross-graph interactions between drugs and proteins.
  • To overcome the limitations of existing methods that process similarity graphs in isolation.

Main Methods:

  • Utilizes pretrained language models for initial embedding generation of drugs and proteins.
  • Constructs similarity graphs from these embeddings.
  • Employs a novel dynamic cross-graph attention (DCGAT) module, incorporating a Graph Convolutional Network-based Cross-Neighborhood Selection network.
  • Dynamically selects cross-modal neighbors to integrate information from both drug and protein modalities via attention mechanisms.

Main Results:

  • DCGAT-DTI demonstrates superior performance compared to state-of-the-art methods on four benchmark datasets.
  • Achieves significant improvements across both balanced and unbalanced datasets, including challenging cold-start scenarios.
  • Shows enhanced prediction accuracy for both drugs and proteins, particularly in unbalanced cold-start conditions.

Conclusions:

  • DCGAT-DTI effectively models interdependencies between drug and protein modalities for improved DTI prediction.
  • The dynamic cross-graph attention mechanism is key to its enhanced performance.
  • The framework offers a promising advancement for accelerating the drug discovery pipeline.